Quick Answer
Arcturus Therapeutics Holdings Inc. reported Stockholders Equity of $213.99 million for fiscal year 2025.
Arcturus Therapeutics Holdings Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $213.99M | -11.2% |
| 2024 | $240.98M | -13.5% |
| 2023 | $278.51M | +3.0% |
| 2022 | $270.31M | +18.4% |
| 2021 | $228.21M | -42.5% |
| 2020 | $396.55M | +1437.5% |
| 2019 | $25.79M | +89.1% |
| 2018 | $13.64M | -59.6% |
| 2017 | $33.79M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $224.56M | -14.2% | -2.8% |
| June 30, 2025 | $231.05M | -10.6% | -1.2% |
| March 31, 2025 | $233.76M | -11.4% | -3.0% |
| December 31, 2024 | $240.98M | -13.5% | -8.0% |
| September 30, 2024 | $261.87M | -6.5% | +1.3% |
| June 30, 2024 | $258.58M | -9.3% | -2.0% |
| March 31, 2024 | $263.97M | -19.8% | -5.2% |
| December 31, 2023 | $278.51M | +3.0% | -0.6% |
- Arcturus Therapeutics Holdings Inc. showed a decrease of -11.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Arcturus Therapeutics Holdings Inc.’s stockholders equity has grown by 533.2% (from $33.79 million to $213.99 million).
- The most recent figure is from Arcturus Therapeutics Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: